The Mechanism of Radiosensitization by YM155, a Novel Small Molecule Inhibitor of Survivin Expression, is Associated with DNA Damage Repair

Songliu Hu,Songbin Fu,Xiangying Xu,Lin Chen,Jianyu Xu,Bin Li,Yuanyuan Qu,Hongyang Yu,Shan Lu,Wenxin Li
DOI: https://doi.org/10.1159/000430245
2015-01-01
Cellular Physiology and Biochemistry
Abstract:Background/Aims: Survivin, a member of the inhibitor of apoptosis protein family, is an attractive target for cancer therapy. We investigated the effects of YM155, a small molecule inhibitor of survivin expression, on the radiosensitivity of human non-small cell lung cancer (NSCLC) cell lines and elucidated a relationship between the cellular localization of survivin and DNA double-strand break repair. Methods: The cellular distribution of survivin was determined by Western blotting of subcellular fractions and by immunofluorescent staining in A549 NSCLC cells. Radiation-induced DNA damage was evaluated based on histone H2AX phosphorylation and foci formation. The relationship between the cellular localization of survivin and DNA double-strand break repair was analyzed by Western blotting and co-immunoprecipitations. Results: YM155 down-regulated survivin expression in NSCLC cells in a concentration- and time-dependent manner. An in vitro clonogenic survival assay revealed that YM155 increased the sensitivity of NSCLC cells to radiation. After irradiation, we observed a rapid accumulation of survivin in the nucleus. An immunofluorescent analysis of histone γ-H2AX demonstrated that the inhibition of survivin expression by YM155 resulted in impaired DNA double-strand break repair. Co-immunoprecipitation assays using nuclear extracts revealed an interaction between survivin, Ku70, γ-H2AX, and DNA-PKcs. Furthermore, S2056 autophosphorylation of DNA-PKcs was reduced in survivin-depleted cells. Conclusions: These results suggested that YM155 sensitized NSCLC cells to radiation, at least in part by inhibiting DNA repair and enhancing apoptosis via the down-regulation of survivin expression. YM155 pretreatment inhibited DNA-PKcs autophosphorylation at S2056. Nuclear survivin was involved in DNA double-strand break repair via interactions with members of the DNA double-strand break repair machinery.
What problem does this paper attempt to address?
This paper aims to explore the effect of the small - molecule inhibitor YM155 on the radiosensitivity of non - small - cell lung cancer (NSCLC) cell lines through down - regulating survivin expression and its mechanism. Specifically, the problems that the researchers want to solve include: 1. **How does YM155 affect the radiosensitivity of NSCLC cells?** Through the colony - forming assay, the researchers evaluated the change in the survival rate of NSCLC cells under radiotherapy after YM155 treatment to determine whether YM155 can enhance the sensitivity of NSCLC cells to radiotherapy. 2. **The relationship between the intracellular localization of survivin and its DNA double - strand break repair function**: The researchers analyzed the distribution of survivin in the nucleus and cytoplasm by Western blotting and immunofluorescence staining techniques and observed its changes after radiation to explore the relationship between the intracellular localization of survivin and DNA damage repair. 3. **How does YM155 affect the DNA damage repair process?** By detecting the formation and duration of γ - H2AX foci, the researchers evaluated the ability of DNA double - strand break repair in NSCLC cells after YM155 treatment to understand whether YM155 increases the radiosensitivity of cells by inhibiting DNA repair. 4. **The interaction between survivin and DNA repair proteins**: Through the co - immunoprecipitation experiment, the researchers explored the interaction between survivin and key DNA repair proteins such as Ku70 and DNA - PKcs to reveal the specific role of survivin in the DNA repair process. In summary, this paper mainly solves the problem of how YM155 affects the radiosensitivity and DNA damage repair ability of NSCLC cells by down - regulating survivin expression. The research results show that by inhibiting the expression of survivin, YM155 not only enhances the sensitivity of NSCLC cells to radiotherapy but also further improves the effect of radiotherapy by interfering with the DNA repair pathway, especially DNA double - strand break repair.